Melanoma Focus Virtual Regional Meeting
Friday 13th May 2022
Organised by: Dr Miranda Payne, Consultant Medical Oncologist, Oxford University Hospitals NHS Foundation Trust
Location: Online - Virtual
Friday, 13th May 2022 | 9:00 am – 5:30 pm |
Programme
09:00 - 09:15 | Welcome/Introductions |
09:15 - 10:00 | Stage II Melanoma: Developments as a result from advances in systemic therapies Associate Professor Alexander van Akkooi, Chair of Melanoma Surgery, Melanoma Institute of Australia |
09:15 – 12:30 | Pharma Exhibition Area / Posters |
10:10 – 10:50 | Virtual Networking: |
11:00 – 12:00 | Pharma Sponsored Symposium: Novartis Survivorship – A new treatment goal for advanced melanoma? |
12:30 – 13:35 | Session 1: Molecular surveillance of melanoma |
12:30 – 12:55 | Circulating tumour DNA; a new tool for the clinic |
12:55 – 13:20 | Biofluid metabolomics – the other liquid biopsy for cancer detection |
13:20 – 13:35 | Q&A |
13:35 – 14:35 | Session 2: Living beyond a stage 4 diagnosis |
13:35 – 14:15 | Caroline Kohl (10 mins), Paul Duhig (10 mins), Dr Shelley Petzer (10 mins) |
14:15 – 14:35 | Q&A |
14:35 – 14:45 | Comfort Break |
14:45 – 16:30 | Session 3: Practice changes in oncology Chair: Dr Ben Fairfax, Wellcome Intermediate Clinical Fellow and Honorary Consultant Medical Oncologist |
14:45 – 15:10 | Using Artificial Intelligence approaches to address an unmet need for melanoma |
15:10 – 15:35 | Findings from the first UK Census of Skin Cancer Specialist Nurses |
15:35 – 16:15 | Melanoma immunotherapy: response and toxicity |
16:15 – 16:30 | Q&A |
16:30 – 17:25 | Session 4: MDT – Management of progression on adjuvant treatment (case-based discussions) |
17:25 – 17:30 | Concluding Remarks and Close |